B7 Family Molecules Are Favorably Positioned at the Human Maternal-Fetal Interface1
Open Access
- 1 May 2003
- journal article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 68 (5) , 1496-1504
Abstract
The human placenta utilizes both active and passive mechanisms to evade rejection by the maternal immune system. We investigated the pattern of expreKeywords
This publication has 59 references indexed in Scilit:
- The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune ResponsesAnnual Review of Immunology, 2002
- Expression of HLA-DR, CAM and co-stimulatory molecules on cord blood monocytesEuropean Journal of Haematology, 2001
- Enhanced Expression of CD80 (B7-1), CD86 (B7-2), and CD40 and Their Ligands CD28 and CD154 in Fulminant Hepatic FailureThe American Journal of Pathology, 1999
- Activation-Induced Expression of Human Programmed Death-1 Gene in T-LymphocytesExperimental Cell Research, 1997
- Differential expression and function of CD80 (B7‐1) and CD86 (B7‐2) on human peripheral blood monocytesImmunology, 1996
- Mechanisms of tolerance to selfCurrent Opinion in Immunology, 1996
- The B7 and CD28 receptor familiesImmunology Today, 1994
- T cell co-stimulation and in vivo toleranceCurrent Opinion in Immunology, 1993
- Immunohistochemical Localization of Interferons in Human Placental Tissues in Normal, Ectopic, and Molar PregnancyAmerican Journal of Reproductive Immunology, 1990
- Amniochorion: Immunologic Aspects—A ReviewAmerican Journal of Reproductive Immunology, 1989